Navigation Links
US HIFU to Showcase High Intensity Focused Ultrasound for the Treatment of Prostate Cancer at AUA
Date:5/17/2012

versity of Cincinnati have joined the U.S. FDA clinical trial. The new sites join such institutions as Walter Reed Medical Center, UCLA, Fox Chase Cancer Center and Indiana University as investigators evaluating the Sonablate® 500 as a possible treatment for recurrent prostate cancer in patients treated previously with radiation therapy.  

The company also announced they will host informal briefing sessions with Dr. Hashim Ahmed and Dr. Mark Emberton of the University College of London Hospital.  The sessions will highlight research being done at UCLH using US HIFU technology for focal therapy, including a recent study using the Sonablate to deliver focal treatment for prostate cancer. The outcome of this initial study indicates HIFU may provide an alternative to traditional treatment with significantly fewer side effects, according to results published in the current issue of Lancet Oncology (DOI:10.1016/S1470-2045(12)70121-3).

In addition, although still investigational in the United States, recent HIFU treatment guidelines have been issued by the National Institute for Health and Clinical Excellence (NICE) of the United Kingdom.  Interventional procedure guidance 424, "Focal therapy using high-intensity focused ultrasound for localised prostate cancer," indicates current evidence on focal therapy using HIFU for localized prostate cancer raises no major safety concerns.

HIFU is a therapy that destroys targeted tissue with rapid heat elevation. HIFU concentrates high frequency ultrasound waves (similar to a magnifying glass) into an area the size of a grain of rice. At that location, or focal point, the temperature rapidly rises to almost 90 degrees Celsius (195 degrees Fahrenheit).  Tissue at the focal point, including cancerous tissue, is destroyed. HIFU uses non-ionizing energy, so the procedure can be repeated, if necessary. HIFU is being studied around the world to treat a wide v
'/>"/>

SOURCE USHIFU, LLC
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. CEL-SCI CEO to Present at the International Society for Pharmaceutical Engineering 2007 Chesapeake BioShowcase
2. Siemens Showcases Its Most Comprehensive and Advanced Breast Care Portfolio
3. ACORN Showcases Oncology CRO, EDC, PRO and Data Warehouse at 44th Annual DIA Meeting
4. InVitria Showcases Cell Culture Productivity Enhancers at BioProcess International
5. Xoft Showcases Interim Clincal Results for Breast Cancer Product and New Indications for Electronic Brachytherapy(eBx) at Astro Meeting
6. InVitrias Cellastim Showcased in Nature Article
7. Anti-Aging Expo & Symposium Showcases in Charlotte on March 28th
8. B. Braun Medical Inc. to Demonstrate Infusion Systems Technologies at HIMSS 2009 Interoperability Showcase
9. Edifecs, CAQH and Harvard Pilgrim Health Care Will Examine CORE Phase II Testing Outcomes and Lessons Learned at HIMSS09 Interoperability Showcase
10. Scottsdale Facility to Be First in U.S. to Showcase True REST Technology
11. King Pharmaceuticals Showcases Data From Pain Pipeline of Medicines Designed to Deter Common Methods of Non-Therapeutic Use
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/27/2014)... , Aug. 27, 2014 Reportlinker.com announces ... in its catalogue: Global Animal Health ... About Animal Health Animal health refers ... or treat animals to enhance their quality of ... of animal food. The Global Animal Health market ...
(Date:8/27/2014)... Kewaunee Scientific Corporation (Nasdaq: KEQU ... quarterly cash dividend by 9% to twelve cents per ... with the dividend payable on September 22, 2014 to ... September 8, 2014. About Kewaunee Scientific ... Corporation is a recognized global leader in the design, ...
(Date:8/27/2014)... , Aug. 27, 2014  UBM Medica US announces ... online community for medical imaging professionals, presents special reporting ... Medical Imaging Management,s 2014 Annual Meeting . ... , 11 Principles of Successful Labor ... to greater profitability. , Why Don,t Patients ...
Breaking Medicine Technology:Global Animal Health Market 2014-2018 2Global Animal Health Market 2014-2018 3Global Animal Health Market 2014-2018 4Global Animal Health Market 2014-2018 5Global Animal Health Market 2014-2018 6Global Animal Health Market 2014-2018 7Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 2Diagnostic Imaging Covers Association for Medical Imaging Management (AHRA) 2014 Meeting 3
... and INDIANAPOLIS, Ind., May 5 A new substudy from ... showed that patients who took prasugrel and had a reduced ... risk of cardiovascular death, heart attack or stroke compared with ... were published online in Circulation on May 4, ...
... Oramed Pharmaceuticals, Inc.,(OTC: ORMP) ( http://www.oramed.com ), a ... clinical trials will commence this week on 30 ... evaluate the safety,tolerability and efficacy of its oral ... (CRO) located in Johannesburg,South Africa, will oversee the ...
Cached Medicine Technology:New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel 2New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel 3New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel 4New Analysis Evaluated Impact of Genetic Variation on Response to Prasugrel 5Oramed Pharmaceuticals Announces Launch of Phase 2B Clinical Trials in South Africa of its Oral Insulin Capsule 2
(Date:8/27/2014)... Home Care Assistance of Scottsdale , ... proud to announce the next installment in its renowned ... Dr. Suzanne Steinbaum, attending cardiologist and Director of Women’s ... City, National Spokesperson for the American Heart Association’s Go ... issues surrounding women and heart disease, what heart disease ...
(Date:8/27/2014)... of clinical trial participation in the largest ongoing observational ... are not representative of the larger patient base, according ... Dr. Jay Udell. The study authors call into question ... population, and suggest the use of broader enrollment criteria ... "We know that clinical trials can be tremendously expensive ...
(Date:8/27/2014)... tested an advanced statistical model to evaluate the ... as published yesterday in Human Genetics . ... in current analyses. Complex diseases like cancer usually ... factors. When many such combinations are studied, identifying ... combinations among affected individuals becomes difficult. In this ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 Cash House ... impact on the overall upkeep of the shelter including new ... importantly helping to change the lives of each youth who ... 35 bed emergency shelter for youth ages 16-25. Not only ... many programs and resources for the youth who come through ...
(Date:8/27/2014)... Lighthouse Payment Services Inc ., a leader ... exhibit its image-based lockbox services at the Independent Bankers ... in beautiful Lake Placid, New York from September 7th ... at the Lake Placid Convention Center and will feature ... addition to a variety of vendors exhibiting the latest ...
Breaking Medicine News(10 mins):Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 2Health News:Home Care Assistance of Scottsdale to Host Webinar on Heart Health, Featuring Dr. Suzanne Steinbaum 3Health News:Participants of cardiac clinic trials do not represent real world patients, study finds 2Health News:Dartmouth isolates environmental influences in genome-wide association studies 2Health News:Cash House a Major Supporter of Horizons for Youth 2Health News:Cash House a Major Supporter of Horizons for Youth 3
... (Carlsbad, CA) and its development partner, Logical Therapeutics, Inc. ... active comparator study of LT-NS001 (formerly MX-1094) vs naproxen, ... LT-NS001 is a novel, patented NCE prodrug of the ... developed to significantly reduce the GI safety risks, including ...
... 30-Year Finance Executive Veteran Adds Public Accounting, Executive ... Smith announced today that Dave Watkins has been ... responsible for overseeing all Company financial functions, including ... forecasts and tax planning. H. D. Smith ...
... Time Spent Caring for Parents with Alzheimer,s in Heartfelt New ... memoirs, "36 Days Apart: A memoir of a daughter, her ... Life, Love and Death" ( published by AuthorHouse ... of her mother and father, both of whom were diagnosed ...
... - Discovery Health,s Seventh Annual Programming Event Presents Baby ... 14, through Friday, June 19 - SILVER SPRING, Md., ... the third week of June to deliver the network,s ... pregnancies, to surprise deliveries, to expectant mothers big and ...
... prebiotics market is diversifying and expanding in ... and beverage industry, with several exciting developments ... and the expansion of prebiotic ingredients into ... and meat products.(Logo: http://www.newscom.com/cgi-bin/prnh/20081117/FSLOGO )New prebiotic ...
... of 14 Hydroxycut products, consumers who have suffered injuries from using ... products liability attorney to determine if he/she is eligible for compensation. ... , ... San Diego, CA (PRWEB) May 26, 2009 ...
Cached Medicine News:Health News:Medinox Announces Clinical Results of Naproxen Prodrug 2Health News:H. D. Smith Appoints Dave Watkins Chief Financial Officer 2Health News:New Memoir Details Effects of Alzheimer's on Family 2Health News:Oh Baby! Discovery Health's BABY WEEK Offers the Most Pregnancies, Births and Drama Anywhere on Television 2Health News:Oh Baby! Discovery Health's BABY WEEK Offers the Most Pregnancies, Births and Drama Anywhere on Television 3Health News:Oh Baby! Discovery Health's BABY WEEK Offers the Most Pregnancies, Births and Drama Anywhere on Television 4Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 2Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 3Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 4Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 5Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 6Health News:European Prebiotics Market Diversifies Strongly Across New Application Sectors in Food and Beverage Industry, Finds Frost & Sullivan 7Health News:LawInfo Provides Access to Qualified Hydroxycut Litigation Attorneys Nationwide 2
... (Penicillin G) inhibits bacterial ... synthesis. Streptomycin belongs to ... inhibits bacterial growth by ... is used for prevention ...
...
Contains 10,000 units of penicillin (base), 10,000 g of streptomycin (base), and 25 g of amphotericin B/ml utilizing penicillin G (sodium salt), streptomycin sulfate, and amphotericin B as Fungizone ...
All BioWhittaker Cell Culture Reagent and Buffer products are manufactured in accordance with cGMP regulations and are cell culture tested to assure compatibility. , Typical Properties, Sterility : ...
Medicine Products: